Elevated Level of Nuclear Protein Kinase C in Multidrug-resistant MCF-7 Human Breast Carcinoma Cells

Cancer Research

Volumn 52, Issue 13, 1992, Pages 3750-3759

  Lee, Sung Ae ^a   Karaszkiewicz, James W ^a   Anderson, Wayne B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL NUCLEUS; CHROMATOGRAPHY, DEAE-CELLULOSE; DOXORUBICIN; DRUG RESISTANCE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0026688919     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Baker, R. M., and Ling, V. Membrane mutants of mammalian cells in culture. In: E. Korn (ed.), Methods in Membrane Biology, Vol. 9, pp. 337-384. New York: Plenum Publishing Corp., 1978.
2. Biedler, J. L., and Peterson, R. H. F. Altered plasma membrane glycocon-jugates of Chinese hamster cells with acquired resistance to actinomycin D., daunorubicin, and vincristine. In: A. C. Sartorelli, J. S. Lazo, and J. R. Bertino (eds.), Molecular Actions and Targets for Cancer Chemotherapeutic Agents, pp. 453-476. New York: Academic Press, 1981.
3. Bradley, G., Naik, M., and Ling, V. P-Glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. Cancer Res., 49: 2790-2796, 1989.
4. Endicott, J. A., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58:137-171, 1989.
5. Pastan, I., and Gottesman, M. Multiple-drug resistance in human cancer. N. Engl. J. Med., 316: 1388-1393,1987.
6. Gottesman, M. M., and Pastan, I. The multidrug transporter, a double-edged sword. J. Biol. Chem., 263:12163-12166, 1988.
7. Greenberger, L. M., Lothstein, L., Williams, S. S., and Horrwitz, S. B. Distinct P-glycoprotein precursors are overproduced in independently isolated drug-resistant cell lines. Proc. Natl. Acad. Sri. USA, 85: 3762-3766, 1988.
8. Somfai-Relle, S., Suzukake, K., Vistica, B. P., and Vistica, D. T. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard. Biochem. Pharmacol., 33: 485-490,1984.
9. Hamilton, T. C., Winkler, M. A., Louie, K. G., Batist, G., Behrens, B., Tsuruo, T., Grotzinger, K. R., Mckoy, W. M., Young, R. C., and Ozols, R. F. Augmentation of Adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian cancer cell lines by buthionine sulfoximine-mediated glutathione depletion. Biochem. Pharmacol., 34: 2583-2589,1985.
10. Batist, G., Tulpule, A., Sinha, B. K., Kathi, A. G., Myers, C. E., and Cowan, K. H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261:15544-15549,1986.
11. Cowan, K. H., Batist, G., Tulpule, A., Sinha, B. K., and Myers, C. E. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc. Natl. Acad. Sci. USA, 83:9328-9332,1986.
12. Mungikar, A., Chitnis, M., and Gothoskar, B. Mixed function oxidase enzymes in Adriamycin-sensitive and -resistant sublines of P388 leukemia. Chem.-Biol. Interact., 35:119-124,1981.
13. Mimnaugh, E. G., Dusre, L., Atwell, J., and Myers, C. E. Differential oxygen radical susceptibility of Adriamycin-sensitive and -resistant MCF-7 human breast tumor cells. Cancer Res., 49:8-15,1989.
14. Fine, R. L., Patel, J., and Chabner, B. A. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. USA, 85:582-586,1988.
15. O'Brian, C. A., Fan, D., Ward, N. E., Seid, C., and Fidler, I. J. Level of protein kinase C activity correlates directly with resistance to Adriamycin in murine fibrosarcoma cells. FEBS Lett., 246:78-82,1989.
16. Ferguson, P. J., and Cheng, Y-C. Transient protection of cultured human cells against antitumor agents by 12-O-tetradecanoyl-13-acetate. Cancer Res., 47:433-441, 1987.
17. Kessel, D. Effects of phorbol esters and doxorubicin transport systems. Biochem. Pharmacol., 37:2297-2299,1987.
18. Thomas, T. P., Talwar, H. S., and Anderson, W. B. Phorbol ester-mediated association of protein kinase C to the nuclear fraction in NIH 3T3 cells. Cancer Res., 48:1910-1919,1988.
19. Mitchell, F. E., Marais, R. M., and Parker, P. J. The phosphorylation of protein kinase C as a measure of activation. Biochem. J., 261: 131-136, 1989.
20. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem., 72:248-254,1976.
21. Manuscripts in preparation.
22. Ono, Y., Fiyii, T., Ogita, K., Kikkawa, U., Igarashi, K., and Nishizuka, Y. The structure, expression, and properties of additional members of the protein kinase C family. J. Biol. Chem., 263:6927-6932, 1988.
23. Schaap, D., and Parker, P. J. Expression, purification, and characterization of protein kinase C-. J. Biol. Chem., 265:7301-7307, 1990.
24. Aquino, A., Hartman, K. D., Knode, M. C., Grant, S., Huang, K. P., Niu, C. H., and Glazer, R. I. Role of protein kinase C in phosphorylation of vinulin in Adriamycin-resistant HL-60 leukemia cells. Cancer Res., 48:3324-3329,1988.
25. Aquino, A., Warren, B. S., Omichinski, J., Hartman, K. D., and Glazer, R. 1. Protein kinase C? is present in Adriamycin resistant HL-60 leukemia cells. Biochem. Biophys. Res. Commun., 166:723-728,1990.
26. Chambers, T. C., McAvoy, E. M., Jacobs, J. W., and Eilon, G. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J. Biol. Chem., 265:7679-7687,1990.
27. Hamada, H., Hagiwara, K. 1., Nakjima, T., and Tsuruo, T. Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res., 47: 2860-2865,1987.
28. Mason-Garcia, M., Weill, C., and Beckman, B. S. Rapid activation by erythropoietin of protein kinase C in nuclei of erythroid progenitor cells. Biochem. Biophys. Res. Commun., 168:490-497,1990.
29. Masmoudi, A., Labourdette, G., Mersel, M., Huang, F. L., Huang, K-P., Vincendon, G., and Malviya, A. N. Protein kinase C located in rat liver nuclei. J. Biol. Chem., 264:1172-1179,1989.
30. Capitani, S., Girard, P. R., Mazzei, G. J., Kuo, J. F., Berezney, R., and Manzoli, F. A. Immunochemical characterization of protein kinase C in rat liver nuclei and subcellular fractions. Biochem. Biophys. Res. Commun., 142:367-375,1987.
31. Chen, Z. Z., McGuire, J. C., Leach, K. L., and Cambigr, J. C. Transmembrane signalling through B cell MHC class II molecules: anti-la antibodies induce protein kinase C translocation to the nuclear fraction. J. Immunol., 138:2345-2352,1987.
32. Fields, A. P., Pettit, G. R., and May, W. S. Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C. J. Biol. Chem., 263: 8253-8260,1988.
33. Leach, K. L., Powers, E. A., Ruff, V. A., Jaken, S., and Kaufmann, S. Type 3 protein kinase C localization to the nuclear envelope of phorbol estertreated NIH 3T3 cells. J. Cell Biol., 109:685-695, 1989.
34. Molina, C. A., Weyman, C. M., and Ashendel, C. L. Regulation of protein kinase C via phosphorylation. Proc. Am. Assoc. Cancer Res., 31:149,1990.
35. Gopalalcrishna, R., and Anderson, W. B. Ca2*-and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. USA, 86:6758-6762, 1989.
36. Gopalakrishna, R., and Anderson, W. B. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys., 285:382-387, 1991.
37. Iwasa, Y., Takai, Y., Kikkawa, U., and Nishizuka, Y. Phosphorylation of calf thymus HI histone by calcium-activated, phospholipid-dependent protein kinase. Biochem. Biophys. Res. Commun., 96:180-187,1985.
38. Roach, A. D., Roach, P. J., Zucker, K. E., and Smith, S. S. Selective phosphorylation of human DNA methyl transferase by protein kinase C. FEBS Lett, 197:149-153,1986.
39. Sahyoun, N., Wolf, M., Besterman, J., Hsieh, T-S., Sander, M., LeVine, H., Chang, K-J., and Cuatrecasas, P. Protein kinase C phosphorylates topoisom-erase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc. Natl. Acad. Sci. USA, 83:1603-1607,1986.
40. Tanaka, Y., Koide, S. S., Yoshihara, K., and Kamiya, T. Poly(ADP-ri-bose)synthetase is phosphorylated by protein kinase C in vitro. Biochem. Biophys. Res. Commun., 148:709-717,1987.
41. Krauss, S. W., Mochly-Rosen, D., Koshland, D. E., Jr., and Linn, S. Exposure of HeLa DNA polymerase a to protein kinase C affects its catalytic properties. J. Biol. Chem., 262:3432-3435,1987.
42. Fields, A. P., Pettit, G. R., and May, W. S., Jr. Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C. J. Biol. Chem., 263: 8253-8260, 1988.
43. Jetten, A. M., Ganong, B. R., Vandenbark, G. R., Shirley, J. E., and Bell, R. M. Role of protein kinase C in diacylglycerol-mediated induction of ornithine decarboxylase and reduction of epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA, 82: 1941-1945,1985.
44. Imagawa, M., Chiu, R., and Karin, M. Transcription factor AP-2 mediates induction by two different signal transduction pathways: protein kinase C and cAMP. Cell, 51:251-260, 1987.
45. McCaffrey, P., Ran, W., Campisi, J., and Rosner, M. R. Two independent growth factor-generated signals regulate c-fos and c-myc mRNA levels in Swiss 3T3 cells. J. Biol. Chem., 262:1442-1445,1987.